Literature DB >> 6154063

Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.

A H Soll.   

Abstract

The effects of prostaglandins E2 and I2 on accumulation of [14C]aminopyrine and the generation of cyclic AMP by fractions of dispersed canine gastric mucosal cells, enriched in their content of parietal cells, have been studied. The parietal cell content of the fractions was enriched to between 43 and 70% using an elutriator rotor. The accumulation of [14C]aminopyrine was used as the index of parietal cell response to stimulation. Prostaglandin E2 (PGE2, 0.1 nM-0.1 mM) inhibited histamine stimulated aminopyrine uptake but did not block the response to carbachol, gastrin, or dibuturyl cyclic AMP. PGE2 did, however, inhibit aminopyrine uptake stimulated by carbachol and gastrin when the response to these agents was potentiated by histamine. PGE2 (0.1 NM-0.1 mM) inhibited histamine-stimulated cyclic AMP production in a dose-dependent fashion with maximal inhibition at 1 microM PGE2. Prostacyclin also inhibited both histamine-stimulated aminopyrine accumulation and histamine-stimulated cyclic AMP production. In the absence of added histamine, PGE2 in concentrations above 1 microM and prostacyclin in concentrations above 10 microM stimulated cyclic AMP production, probably by acting on the nonparietal cells as shown in previous studies. These present data are consistent with the hypothesis that prostaglandins E2 and I2 inhibit the response of isolated parietal cells to histamine by specifically blocking histamine-stimulated cyclic AMP production.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154063      PMCID: PMC371456          DOI: 10.1172/JCI109777

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides.

Authors:  A L Steiner; C W Parker; D M Kipnis
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

2.  Effect of prostaglandins on guinea pig myocardial adenyl cyclase.

Authors:  I Klein; G S Levey
Journal:  Metabolism       Date:  1971-09       Impact factor: 8.694

3.  Adenyl cyclase activity in human platelets.

Authors:  S M Wolfe; N R Shulman
Journal:  Biochem Biophys Res Commun       Date:  1969-04-29       Impact factor: 3.575

4.  Inhibition of gastric acid secretion in vitro by prostaglandin E1.

Authors:  L Way; R P Durbin
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

5.  Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues.

Authors:  R W Butcher; C E Baird
Journal:  J Biol Chem       Date:  1968-04-25       Impact factor: 5.157

6.  The effect of prostaglandin E 1 on canine gastric acid secretion and gastric mucosal blood flow.

Authors:  D E Wilson; R A Levine
Journal:  Am J Dig Dis       Date:  1972-06

7.  The effect of prostaglandin E 1 on the pentagastrin-stimulated gastric secretion in man.

Authors:  M Classen; H Koch; J Bickhardt; G Topf; L Demling
Journal:  Digestion       Date:  1971       Impact factor: 3.216

8.  Prostaglandin inhibition of gastric secretion.

Authors:  P W Ramwell; J E Shaw
Journal:  J Physiol       Date:  1968-03       Impact factor: 5.182

9.  Effect of prostaglandin E 1 on certain renal actions of parathyroid hormone.

Authors:  N P Beck; F R DeRubertis; M F Michelis; R D Fusco; J B Field; B B Davis
Journal:  J Clin Invest       Date:  1972-09       Impact factor: 14.808

10.  Cyclic 3',5'-adenosine monophosphate in the human lukocyte: synthesis, degradation, andeffects n neutrophil candidacidal activity.

Authors:  H R Bourne; R I Lehrer; M J Cline; K L Melmon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

View more
  30 in total

Review 1.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

2.  Isolation, identification and quantitative evaluation of specific cell types from the mammalian gastric mucosa.

Authors:  M Beinborn; J Giebel; M Linck; Y Cetin; M Schwenk; K F Sewing
Journal:  Cell Tissue Res       Date:  1993-11       Impact factor: 5.249

3.  Somatostatin stimulates prostaglandin production by rat gastric epithelial cells in vitro, but is not cytoprotective.

Authors:  M Romano; M Razandi; K J Ivey
Journal:  Dig Dis Sci       Date:  1988-11       Impact factor: 3.199

Review 4.  Physiology and pharmacology of prostaglandins.

Authors:  S J Konturek; W Pawlik
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

5.  Histamine-sensitive adenylate cyclase in human gastric mucosa: cellular localization and interaction by PGE2, somatostatin and secretin.

Authors:  H J Ruoff; M Becker
Journal:  Agents Actions       Date:  1982-04

6.  Are prostaglandins involved in somatostatin mediated inhibition of gastric secretion in the cat?

Authors:  M Albinus; G Frisch
Journal:  Agents Actions       Date:  1986-04

7.  Somatostatin inhibits gastric acid secretion after gastric mucosal prostaglandin synthesis inhibition by indomethacin in man.

Authors:  M H Mogard; V Maxwell; T Kovacs; G Van Deventer; J D Elashoff; T Yamada; G L Kauffman; J H Walsh
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

8.  Effect of hydrochloric acid and prostaglandins on pepsinogen synthesis and secretion in canine gastric chief cell monolayer cultures.

Authors:  J Defize; R H Hunt
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

9.  The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach.

Authors:  S P Canfield; J E Spencer
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

10.  Cyclic GMP and acid production in isolated gastric cells of the rat.

Authors:  H K Heim; H J Ruoff
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.